ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Zhongmin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8358-3074; OpenAlex author ID A5063354278. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 11

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell axis in MHC-I deficient pancreatic cancer. Last author DOI 10.1016/j.canlet.2025.217620 ↗
HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer. Last author DOI 10.1111/jcmm.17254 ↗
PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation. Co-author DOI 10.1111/jcmm.14896 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaoyu Liu · 2 shared papers, 2022–2025 · strength 0.37
- Paper Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell ax… DOI 10.1016/j.canlet.2025.217620 ↗
- Paper HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resista… DOI 10.1111/jcmm.17254 ↗
Wenguo Cui · 1 shared paper, 2025 · strength 0.21
- Paper Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell ax… DOI 10.1016/j.canlet.2025.217620 ↗
Zhuozhuo Wu · 1 shared paper, 2025 · strength 0.21
- Paper Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell ax… DOI 10.1016/j.canlet.2025.217620 ↗
Chenlei Wen · 1 shared paper, 2025 · strength 0.21
- Paper Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell ax… DOI 10.1016/j.canlet.2025.217620 ↗
Ning Xia · 1 shared paper, 2022 · strength 0.16
- Paper HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resista… DOI 10.1111/jcmm.17254 ↗
Wei Huang · 1 shared paper, 2022 · strength 0.16
- Paper HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resista… DOI 10.1111/jcmm.17254 ↗
Nannan Yang · 1 shared paper, 2022 · strength 0.16
- Paper HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resista… DOI 10.1111/jcmm.17254 ↗
Jun Ma · 1 shared paper, 2020 · strength 0.11
- Paper PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation. DOI 10.1111/jcmm.14896 ↗
Aiwu Mao · 1 shared paper, 2020 · strength 0.11
- Paper PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation. DOI 10.1111/jcmm.14896 ↗
Mingyi Shang · 1 shared paper, 2020 · strength 0.11
- Paper PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation. DOI 10.1111/jcmm.14896 ↗
Bingyan Liu · 1 shared paper, 2020 · strength 0.11
- Paper PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation. DOI 10.1111/jcmm.14896 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.